Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Fabrice Andre"'
Autor:
Ludovic Lacroix, Aldo Scarpa, Vivek Subbiah, Justin F. Gainor, J.-Y. Scoazec, Nicola Normanno, Matteo Repetto, Carmen Belli, Frédérique Penault-Llorca, J.-Y. Douillard, M. Ladanyi, Giuseppe Curigliano, A. Drilon, Volker Endris, Fabrice Andre, Jorge S. Reis-Filho
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2021, ⟨10.1016/j.annonc.2020.11.021⟩
Annals of Oncology, Elsevier, 2021, ⟨10.1016/j.annonc.2020.11.021⟩
International audience; Aberrant activation of RET is a critical driver of growth and proliferation in diverse solid tumours. Multikinase inhibitors (MKIs) showing anti-RET activities have been tested in RET-altered tumours with variable results. The
Autor:
Jean-Yves Scoazec, Sara Faouzi, Amandine Bastide, Fabrice Andre, Shensi Shen, Séverine Roy, Emilie Routier, Hélène Malka-Mahieu, Caroline Robert, Yu Fu, Laurent Désaubry, Alexandre David, Alexander M.M. Eggermont, Stéphan Vagner, Xiaoxiao Sun, Christine Mateus, Sylvain Martineau
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
Nature Communications
Nature Communications, Nature Publishing Group, 2019, 10 (1), ⟨10.1038/s41467-019-13360-6⟩
Nature Communications
Nature Communications, Nature Publishing Group, 2019, 10 (1), ⟨10.1038/s41467-019-13360-6⟩
Cancer persister cells tolerate anticancer drugs and serve as the founders of acquired resistance and cancer relapse. Here we show that a subpopulation of BRAFV600 mutant melanoma cells that tolerates exposure to BRAF and MEK inhibitors undergoes a r
Autor:
Peter Schmid, J. Cortes, Giuseppe Curigliano, N. Turner, Sara A. Hurvitz, E. de Azambuja, S. Loibl, D. Krug, Deborah Fenlon, S. Paluch-Shimon, Mark E. Robson, S-A. Im, Carlos H. Barrios, Christian F. Singer, W.G. Kunz, Rebecca Dent, Sara M. Tolaney, Fabrice Andre, Joseph Gligorov, Sherene Loi, Angela DeMichele, Frédérique Penault-Llorca, Tanja Spanic, Jens Ricke, Hope S. Rugo, Cristina Saura, Alessandra Gennari, Nadia Harbeck
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2021, ⟨10.1016/j.annonc.2021.09.019⟩
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Annals of Oncology, Elsevier, 2021, ⟨10.1016/j.annonc.2021.09.019⟩
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Sin financiación 32.976 JCR (2020) Q1, 7/242 Oncology 8.590 SJR (2021) Q1, 2/133 Hematology No data IDR 2020 UEM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec4f85d47e005f4f53021deb511dd030
https://hal.archives-ouvertes.fr/hal-03428164
https://hal.archives-ouvertes.fr/hal-03428164
Autor:
Barbara Pistilli, Marta Jimenez, Thomas Bachelot, Fabrice Andre, Keyvan Rezai, Julia Salleron, Laurence Vanlemmens, Jean-Louis Merlin, Mario Campone, Valérie Seegers, Qing Wang, Maëva Lion, Agnès Leroux, Gilles Paintaud, Isabelle Treilleux, Delphine Loussouarn, Véronique Diéras, Monica Arnedos, Maria Rios
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Elsevier, 2021, 158, pp.169-180. ⟨10.1016/j.ejca.2021.09.017⟩
European Journal of Cancer, 2021, 158, pp.169-180. ⟨10.1016/j.ejca.2021.09.017⟩
European Journal of Cancer, Elsevier, 2021, 158, pp.169-180. ⟨10.1016/j.ejca.2021.09.017⟩
European Journal of Cancer, 2021, 158, pp.169-180. ⟨10.1016/j.ejca.2021.09.017⟩
Introduction Resistance to trastuzumab in breast cancer is an ongoing challenge. Clinical and biological effects of co-targeting HER2 and mammalian target of rapamycin (mTOR) in patients with HER2-positive early operable breast cancer via the additio
Autor:
Hui Chen, Fabrice Andre, Gerasimos Anagnostopoulos, Frédéric Fumeron, Isabelle Martins, Antoine Lafarge, François Goldwasser, Franziska Grundler, Frank Madeo, Maria Castedo, Benoit Blanchet, Safae Terrisse, Ines Vaz-Luis, Adrien Joseph, Omar Motiño, Françoise Wilhelmi de Toledo, Ronan Roussel, Laurence Zitvogel, Karine Clément, Anne Laure Martin, Maria Chiara Maiuri, Léa Montégut, Guido Kroemer
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 12, Iss 6, Pp 1-14 (2021)
Cell Death and Disease
Cell Death and Disease, 2021, 12 (6), pp.599. ⟨10.1038/s41419-021-03864-9⟩
Cell Death and Disease, Nature Publishing Group, 2021, 12 (6), pp.599. ⟨10.1038/s41419-021-03864-9⟩
Cell Death and Disease, Vol 12, Iss 6, Pp 1-14 (2021)
Cell Death and Disease
Cell Death and Disease, 2021, 12 (6), pp.599. ⟨10.1038/s41419-021-03864-9⟩
Cell Death and Disease, Nature Publishing Group, 2021, 12 (6), pp.599. ⟨10.1038/s41419-021-03864-9⟩
In mice, the plasma concentrations of the appetite-stimulatory and autophagy-inhibitory factor acyl-coenzyme A binding protein (ACBP, also called diazepam-binding inhibitor, DBI) acutely increase in response to starvation, but also do so upon chronic
Autor:
Lisa Derosa, Severine Mouraud, Charles Dussiau, Annabelle Stoclin, Cyril Catelain, Aurélien Marabelle, Lai Guan Ng, Fanny Pommeret, Bertrand Gachot, Frank Griscelli, Aymeric Silvin, Alexia Alfaro, Nathalie Droin, Luc Mouthon, Damien Drubay, Clémence Hénon, Elise Sourdeau, Anne-Sophie Lhonneur, Véronique Saada, Muriel Andrieu, Zheng Zhang, Frédéric Pène, Laurence Zitvogel, T.-A. Szwebel, Pierre Bost, Florent Ginhoux, Anne-Gaëlle Goubet, Delphine Cantin, Nicolas Chapuis, Fabrice Andre, Carole Almire, Olivier Kosmider, Garett Dunsmore, Christophe Willekens, Ido Amit, Marc Deloger, Eric Solary, Chloé Friedrich, Nathalie Marin, Delphine Bredel, Philippe Rameau, Agathe Dubuisson, Didier Borderie, Fabrice Barlesi, Michaela Fontenay
Publikováno v:
Cell
Cell, Elsevier, 2020, 182, pp.1401-1418.e18. ⟨10.1016/j.cell.2020.08.002⟩
Cell, Elsevier, 2020, 182, pp.1401-1418.e18. ⟨10.1016/j.cell.2020.08.002⟩
Summary Blood myeloid cells are known to be dysregulated in the coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2. It is unknown whether the innate myeloid response differs with disease severity, and whether markers of innate immunity discrimi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c2e0c8c3a3f4e0b10395f9056a269c
https://hal.archives-ouvertes.fr/hal-03491454
https://hal.archives-ouvertes.fr/hal-03491454
Autor:
Fathia Mami-Chouaib, Vincent Cattoir, Guido Kroemer, Mohamed Sassi, Krisztián Papp, Nathalie Labarrière, Valerio Iebba, Valentin Quiniou, Romain Boidot, Zsofia Sztupinszki, Nicola Segata, Ivo G. Boneca, Friedemann Loos, Sylvain Simon, Jacques Bou-Khalil, Richard J. Wheeler, Carlos López-Otín, Andréanne Gagné, Luisa De Sordi, Barbara S. Sixt, Philippe Joubert, Clara-Maria Scarlata, Fabien Lemaitre, Peng Liu, Laurent Debarbieux, Alexander M.M. Eggermont, Paola Nisticò, Didier Raoult, David Klatzmann, Connie P.M. Duong, Belinda Palermo, Lisa Derosa, Maha Ayyoub, Maryam Tidjani Alou, Meriem Messaoudene, B. Escudier, François Ghiringhelli, Aurélie Fluckiger, Gladys Ferrere, Saber Khelaifia, Bertrand Routy, Laurence Albiges, Edoardo Pasolli, Anne Gaëlle Goubet, Zoltan Szallasi, Romain Daillère, István Csabai, Laurence Zitvogel, Fabrice Andre, Francesco Facciolo, Corentin Richard, Catherine Rabu
Publikováno v:
Science
Science, 2020, 369 (6506), pp.936-942. ⟨10.1126/science.aax0701⟩
Science, American Association for the Advancement of Science, 2020, 369 (6506), pp.936-942. ⟨10.1126/science.aax0701⟩
Science, 2020, 369 (6506), pp.936-942. ⟨10.1126/science.aax0701⟩
Science, American Association for the Advancement of Science, 2020, 369 (6506), pp.936-942. ⟨10.1126/science.aax0701⟩
International audience; Intestinal microbiota have been proposed to induce commensal-specific memory T cells that cross-react with tumor-associated antigens. We identified major histocompatibility complex (MHC) class I-binding epitopes in the tail le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::851eb8345a07e0270dec4ff3975ab1eb
https://www.hal.inserm.fr/inserm-02923397
https://www.hal.inserm.fr/inserm-02923397
Autor:
Olivier Tredan, Cecile Vicier, Thibault Dayris, Olivia Fromigué, Ibrahim Bouakka, Bojana Stefanovska, Véronique Scott, Anna Rocca, Olivia Le Saux, Fabrice Andre, Suzette Delaloge, Thomas Bachelot, Vasily Ogryzko
Publikováno v:
Cancer Research
Cancer Research, American Association for Cancer Research, 2020, 80 (11), pp.2190-2203. ⟨10.1158/0008-5472.CAN-19-2366⟩
Cancer Research, 2020, 80 (11), pp.2190-2203. ⟨10.1158/0008-5472.CAN-19-2366⟩
Cancer Research, American Association for Cancer Research, 2020, 80 (11), pp.2190-2203. ⟨10.1158/0008-5472.CAN-19-2366⟩
Cancer Research, 2020, 80 (11), pp.2190-2203. ⟨10.1158/0008-5472.CAN-19-2366⟩
Rapalogs have become standard-of-care in patients with metastatic breast, kidney, and neuroendocrine cancers. Nevertheless, tumor escape occurs after several months in most patients, highlighting the need to understand mechanisms of resistance. Using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf0c777d140ecb278ed542caff1cb62f
https://www.hal.inserm.fr/inserm-02768801/file/2190.full.pdf
https://www.hal.inserm.fr/inserm-02768801/file/2190.full.pdf
Autor:
Maud Ngo-Camus, Jeanne Chen, Anas Gazzah, Etienne Rouleau, Cécile Jovelet, David Planchard, Luc Friboulet, Gilles Vassal, Diego Enrico, Jordi Remon, Ludovic Lacroix, Stefan Michiels, Laura Mezquita, Christophe Massard, Gonzalo Recondo, Jean-Charles Soria, Jean-Yves Scoazec, Fabrice Andre, Benjamin Besse, Francesco Facchinetti, Yohann Loriot, Lambros Tselikas
Publikováno v:
JTO Clinical and Research Reports
JTO Clinical and Research Reports, Vol 1, Iss 2, Pp 100023-(2020)
JTO Clinical and Research Reports, Vol 1, Iss 2, Pp 100023-(2020)
Introduction Despite initial benefit, virtually all patients suffering from EGFR-mutant NSCLC experience acquired resistance to tyrosine kinase inhibitors (TKIs), driven by multiple mechanisms. Recent reports have identified oncogenic kinase fusions
Autor:
Alexandra Jacquet, Alicia Tran Dien, Guillaume Meurice, Marta Jimenez, Charlotte K.Y. Ng, Salvatore Piscuoglio, Semih Dogan, Yahia Adnani, Christophe Le Tourneau, Mario Campone, Jean-Charles Soria, Maud Kamal, Max Chaffanet, Thomas Filleron, François Bertucci, Thomas Bachelot, Nadine Carbuccia, Maria R. De Filippo, Anne Patsouris, Claudia Lefeuvre, Daniel Birnbaum, Florence Dalenc, Naveen Babbar, Benjamin Verret, Nathalie Droin, Séverine Garnier, Hervé Bonnefoi, Fabrice Andre
Publikováno v:
Nature
Nature, 2019, 572 (7767), pp.E7-E7. ⟨10.1038/s41586-019-1380-3⟩
Nature, Nature Publishing Group, 2019, 572 (7767), pp.E7-E7. ⟨10.1038/s41586-019-1380-3⟩
Nature, 2019, 572 (7767), pp.E7-E7. ⟨10.1038/s41586-019-1380-3⟩
Nature, Nature Publishing Group, 2019, 572 (7767), pp.E7-E7. ⟨10.1038/s41586-019-1380-3⟩
International audience; An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d85b0fb8561e5c1fb5c00b3912e2b57
https://hal.science/hal-02504834
https://hal.science/hal-02504834